Insights From ERA 2026

This DataPulse Video Brief series from ERA 2026 explores emerging clinical data on finerenone across diverse chronic kidney disease (CKD) populations. Faculty experts Dr. Hiddo Heerspink, Dr. Brendon Neuen, and Dr. Rajiv Agarwal review findings from FIND-CKD, INFINITY, and subgroup analyses in glomerulonephritis, highlighting efficacy and safety outcomes in patients with and without diabetes.

Across the series, discussions examine the evolving role of mineralocorticoid receptor antagonism in CKD management, focusing on slowing kidney disease progression, reducing albuminuria and cardiovascular risk, and addressing hyperkalemia considerations.

Designed for nephrologists, these briefs provide concise insight into data that may help inform treatment strategies across the CKD spectrum.